Longevity Biotech Boom: GLP-1 Drugs, Senolytics and the Future of Anti-Aging Medicine
In the past 48 hours, the biohacking industry shows steady momentum in longevity biotech, with no major disruptions but growing institutional investment and product buzz. Global R&D spending on longev...
14 Apr 2min
Mitochondrial Health Meets Wellness Culture: The Rise of Community Biohacking in 2026
In the past 48 hours, the biohacking industry shows steady momentum in mitochondrial health and experiential wellness, with no major market disruptions or regulatory shifts reported. Mitolyn, a mitoch...
13 Apr 2min
Biohacking Goes Mainstream: Peptides, Supply Chains, and the Future of Human Optimization
In the past 48 hours, the biohacking industry shows steady momentum toward mainstream longevity pursuits, with no major disruptions but growing supply chain concerns and consumer experimentation.[1][2...
10 Apr 2min
Biohacking Booms: Nootropics, Peptides, and Longevity Drive 134 Billion Dollar Industry by 2030
In the past 48 hours, the biohacking industry shows steady momentum driven by cognitive optimization and longevity trends, with no major market disruptions or regulatory shifts reported. Global market...
9 Apr 1min
Biohacking Boom: RFK Jr Pushes FDA Reform as Peptide Market Explodes to 12B
Biohacking Industry Analysis: Past 48 HoursThe biohacking industry is experiencing cautious optimism driven by regulatory advocacy and growing consumer interest in peptides and nootropics.[1] RFK Jr. ...
8 Apr 2min
Biohacking Boom: RFK Jr Pushes FDA Peptide Deregulation as NAD Market Soars to 12B
In the past 48 hours, the biohacking industry displays cautious optimism fueled by regulatory advocacy and surging consumer interest in peptides and nootropics.[1] RFK Jr. has intensified calls for FD...
7 Apr 1min
Peptide Policy Shifts: RFK Jr. Pushes FDA Deregulation While Biohacking Booms
In the past 48 hours, the biohacking industry shows cautious optimism amid regulatory buzz and rising consumer interest in peptides and nootropics. RFK Jr. continues advocating for easier access to 14...
6 Apr 1min
Unregulated Peptides: The Biohacking Industry's $30B Longevity Boom vs Growing Safety Risks
In the past 48 hours, the biohacking industry faces growing scrutiny over unregulated peptides, even as its longevity sector holds a robust 30 billion dollar valuation. A Telegraph report highlights i...
3 Apr 1min
